Related Experiment Videos
[Hormonal therapy in systemic lupus erythematosus].
Dusanka Martinović Kaliterna1, Danijela Marasović Krstulović, Mislav Radić
1Odsjek za klinicku imunologiju i reumatologiju, Klinika za unutarnje bolesti Klinicki bolnicki centar Split, Soltanska 1, 21000 Split.
Reumatizam
|May 1, 2010
Summary
Estrogen exposure, including oral contraceptives and hormone therapy, is linked to systemic lupus erythematosus (SLE) development or worsening. While some therapies show benefits, they may increase thrombosis risk, necessitating individualized treatment for SLE patients.
Area of Science:
- Endocrinology
- Rheumatology
- Immunology
Context:
- Estrogen exposure is frequently associated with the development or exacerbation of systemic lupus erythematosus (SLE).
- Previous research highlights links between oral contraceptives, hormone replacement therapy, and SLE.
- Emerging studies present a complex picture regarding hormonal therapies in SLE patients.
Purpose:
- To review the multifaceted relationship between estrogen exposure and systemic lupus erythematosus.
- To evaluate the clinical implications of hormonal therapies in SLE management.
- To emphasize the need for personalized treatment strategies in SLE patients undergoing hormonal therapy.
Summary:
- Estrogens are known to promote the development and/or worsening of systemic lupus erythematosus (SLE).
- Numerous reports link estrogen exposure from oral contraceptives and menopause hormonal therapy to SLE.
- Recent studies indicate potential benefits from certain hormonal therapies without altering lupus activity but increasing thrombosis risk.
Impact:
- Hormonal therapy decisions for SLE patients require careful consideration of individual clinical presentation and disease progression.
- Understanding the dual effects of hormonal therapy—potential benefits versus thrombosis risk—is crucial for patient care.
- This review underscores the importance of personalized medicine in managing SLE patients with hormonal therapy.
Related Concept Videos
01:22Hormonal Regulation of the Menstrual Cycle
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.
01:19Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
01:22Target Cell Response to Hormones
Hormones intricately bind to receptors on the surface or within target cells, initiating a cascade of cellular responses.
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...